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Abstract. Estimates of malaria transmission intensity (MTI) typically rely upon microscopy or rapid diagnostic test-
ing (RDT). However, these methods are less sensitive than nucleic acid amplification techniques and may underesti-
mate parasite prevalence. We compared microscopy, RDT, and polymerase chain reaction (PCR) for the diagnosis of
Plasmodium falciparum parasitemia as part of an MTI study of 800 children and adults conducted in Lilongwe, Malawi.
PCR detected more cases of parasitemia than microscopy or RDT. Age less than 5 years predicted parasitemia
detected by PCR alone (adjusted odds ratio = 1.61, 95% confidence interval = 1.09–2.38, Wald P = 0.02). In addition,
we identified one P. falciparum parasite with a false-negative RDT result due to a suspected deletion of the histidine-
rich protein 2 (hrp2) gene and used a novel, ultrasensitive PCR assay to detect low-level parasitemia missed by tradi-
tional PCR. Molecular methods should be considered for use in future transmission studies as a supplement to RDT
or microscopy.
Plasmodium falciparum infects hundreds of millions of
individuals and kills 600,000 persons every year.1 A recently
completed phase three trial of the RTS,S/ASO1 malaria
vaccine demonstrated moderate and varying efficacy in
different transmission settings.2 Study sites conducted annual
malaria transmission intensity (MTI) studies during the trial
using microscopy and rapid diagnostic test (RDT) parasite
prevalence as a surrogate for transmission intensity.
Both microscopy and RDT are known to produce negative
results in Africa when parasitemia levels are beneath their
limits of detection, 50 and 200 parasites/μL blood, respec-
tively.3–5 Infections not detected by microscopy or RDT, often
referred to as subpatent infections, can often be detected by
nucleic acid detection methods.6 Though infections detected
by microscopy and RDT are likely responsible for the major-
ity of transmission, further studies are needed to assess the
impact of subpatent infections on the transmission reservoir.7,8
In the context of vaccine trials, these low-level, subpatent
parasitemias may confound estimates of transmission inten-
sity used to study vaccine efficacy.
To evaluate the impact of subpatent parasitemias on para-
site prevalence estimates, we collected dried blood spots from
all participants during the final year of the 3-year MTI study
in Lilongwe, Malawi, to allow for nucleic acid detection of
parasitemia. Using clinical data and a spatial database to
evaluate ecological factors that may influence transmission,
we attempted to identify risk factors for subpatent para-
sitemia. We also investigated the impact of other factors
on discordances between polymerase chain reaction (PCR)
and other assays (RDT and microscopy) including 1) non-
falciparum parasitemia, 2) the occurrence of histidine-rich
protein 2 (hrp2) gene deletions on false-negative RDTs,
and 3) low-level parasitemia detectable by ultrasensitive
PCR targeting high copy number genes.9 This work adds to
the growing literature concerning the relationship between
testing characteristics for malaria detection and provides
new information about hrp2 deletions in Malawi, and the
use of ultrasensitive, falciparum-specific, high-copy telomere-
associated repetitive element 2 (TARE-2) PCR to address
diagnostic discordances.
The MTI study was conducted in Lilongwe from 2011 to
2013 within the catchment area of the phase three RTS,S/
ASO1 trial.2 A total of 800 participants were included each
year from randomly selected households in the area sur-
rounding the Malawi Ministry of Health Area 18 Health
Center in Lilongwe. Each annual cohort of enrollees in the
MTI study included 400 subjects ≥ 6 months and < 5 years
of age, 200 subjects ≥ 5 years of age and < 20 years of age,
and 200 subjects ≥ 20 years of age. Participants in the phase
three RTS,S/ASO1 trial were excluded from the MTI study.
This study includes only the 2013 cohort, all of whom had
a finger prick with blood collected for RDT and micros-
copy and dried on Whatman 3 filter paper (GE Healthcare,
Piscataway, NJ). Microscopy slides were read by two expert
microscopists who received training every 4 months, with
discordances referred to a third microscopist. RDT testing
was performed using SD Bioline HRP-2 Kits (Gyeonggi-do,
Republic of Korea). Filter papers were labeled with an iden-
tifier and stored individually with dessicant at 20°C. This
study was approved by the Malawian National Health Sci-
ences Research Committee and the University of North
Carolina (UNC) Institutional Review Board. All participants
provided written informed consent.
DNA was extracted from filter paper using the PureLink
Pro 96 Genomic DNA Purification Kit (Life Technolo-
gies, Grand Island, NY) at UNC. We used a predeter-
mined screening algorithm for testing samples (Figure 1
and Supplemental Table 1). Initial testing for parasitemia
involved a real-time PCR assay to detect the falciparum-
specific lactate dehydrogenase (pfldh) gene.10 All samples
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were tested with 1 μL of template DNA per reaction in
duplicate, followed by 4 μL of template DNA in duplicate
for discordant replicates and for microscopy-positive, PCR-
negative samples.
The clinical characteristics of subjects were compared
using Fisher’s exact test for categorical variables, the Stu-
dent’s t test for normally distributed continuous variables,
and the Wilcoxon rank-sum test for non-normally distributed
continuous variables. Risk factors for subpatent malaria were
investigated by constructing a binomial regression model. We
used directed acyclic graphs to assess all possible relation-
ships between risk factors of interest and subpatent malaria
and to identify potential confounders. We calculated crude
and adjusted odds ratios for each risk factor. Kappa statistics
were calculated to quantify the agreement between diagnos-
tic testing methods in subjects who underwent testing with
all three methods (PCR, microscopy, and RDT), in addition
to sensitivity and specificity using PCR as the gold standard.
Statistical analyses were performed using SAS 9.4 (SAS Insti-
tute, Cary, NC).
The majority of malaria infections identified in 2013 were
subpatent (Table 1 and Figure 2). This finding was most
prominent among children younger than 5 years, in whom
RDT and microscopy failed to detect two-thirds of all PCR-
positive parasitemias. These children were more likely to
have subpatent malaria than patent malaria, defined as PCR
positive and either microscopy or RDT positive (P = 0.04).
Subjects with subpatent and patent malaria had similar demo-
graphic and clinical characteristics (Table 1). Modeling con-
firmed that age less than 5 years predicted subpatent malaria
in our cohort (adjusted odds ratio = 1.61, 95% confidence
interval [CI] = 1.09–2.38, Wald P = 0.02; Supplemental
Table 2). Neither bed net use nor anemia predicted sub-
patent malaria in the crude or adjusted models.
PCR was the most sensitive diagnostic test for parasitemia,
producing a prevalence 76% higher than microscopy and
16% higher than RDT in 2013. Malaria was detected by
pfldh PCR in 79 (10.0%) subjects, by microscopy in 45
(5.7%), and by RDT in 68 (8.6%). There was moderate
agreement between all the three tests (Figure 2). RDT and
microscopy had the highest level of agreement (kappa =
0.64, 95% CI = 0.54–0.74), PCR and microscopy had less
agreement (kappa = 0.50, 95% CI = 0.38–0.61), and PCR
and RDT had the lowest level of agreement (kappa = 0.44,
95% CI = 0.33–0.54). Using PCR as the gold standard, both
microscopy and RDT lacked sensitivity but were specific.
For microscopy, the sensitivity and specificity were 41.8%
(95% CI = 30.952.7) and 98.3% (95% CI = 97.4–99.3),
whereas RDT had a sensitivity and specificity of 45.6%
(95% CI = 34.6–56.6) and 95.5% (95% CI = 94.0–97.0).
Among 12 subjects with indeterminant microscopy results
(microscopy positive but RDT and pfldh PCR negative),
there were no cases of non-falciparum malaria, but one
subject with parasitemia below the pfldh PCR assay’s limit
of detection was detected using ultrasensitive TARE-2 PCR
(Figure 1). All 26 subjects evaluated for possible RDT
false-positive results (RDT positive but microscopy and
pfldh PCR negative) had negative TARE-2 PCR results.
FIGURE 1. Diagnostic testing algorithm and results.
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Notably, one parasite detected by both PCR and microscopy
but not detected by RDT likely harbored a deletion of
the hrp2 gene, which is responsible for production of the
antigen detected by most RDTs. The geographical distribu-
tion of positive test results by PCR, microscopy, and RDT
was similar.
These results confirm that studies that rely upon RDT and/
or microscopy underestimate malaria prevalence. The striking
difference in parasitemia prevalence estimates among children
younger than 5 years is especially concerning, as these chil-
dren are at highest risk of malaria-related morbidity and
mortality.1 Even if most subpatent infections in these young
children are asymptomatic, they may represent a transmis-
sion reservoir that requires further study and may need to be
addressed by ongoing malaria control efforts.6
Age less than 5 years was a risk factor for subpatent
malaria in our cohort, a finding that differs from other pub-
lished reports. Specifically, submicroscopic malaria has been
associated with older age, presumably due to partial immu-
nity.6,15,16 Although high levels of bed net usage during the
study period suggested that bed nets may be partly responsi-
ble for this finding, bed net usage was not a risk factor for
subpatent infection in our models, a finding consistent with
prior reports.16 Submicroscopic infections are also thought to
be more common in settings of low transmission intensity.11,17
Because PCR testing was only performed in the final year of
the study, we could not assess changes in subpatent malaria
over time.
Using individual-level data, we found a lower level of con-
cordance between microscopy and RDT results than a recent
analysis of prevalence studies, which depended upon cluster-
level data.6,10 Although malaria prevalence as determined by
PCR and RDT differed by only 16%, there was only moder-
ate agreement between tests (kappa = 0.44), likely due in
part to the large number of “false-positive” RDT results
(Figures 1 and 2). “False-positive” RDT results have been
described in the setting of persistent circulating HRP2 antigen
after clearance of P. falciparum parasitemia, indicating not a
failure of the assay itself but recently resolved malaria.5,18,19
We confirmed the absence of low-level parasitemia in samples
with false-positive RDT results using TARE-2 PCR, a novel
ultrasensitive PCR assay that can detect P. falciparum para-
sitemias of 0.03–0.15 parasites/μL blood. We also used this
FIGURE 2. Proportional Venn diagram comparing Plasmodium
falciparum prevalence by diagnostic method. Number of results and
percent overall prevalence by testing method. Diagram was gener-
ated using eulerAPE, version 3.0.0.14
TABLE 1
Patient characteristics
Entire cohort Patent malaria Subpatent malaria P value
N (%) 800 (100) 38 (4.8) 42 (5.3) –
Age (years), n (%)
< 5 400 (50.0) 11 (29.0) 22 (52.4) 0.04
≥ 5 to < 20 200 (25.0) 16 (42.1) 11 (26.2) 0.16
≥ 20 200 (25.0) 11 (29.0) 9 (21.4) 0.45
Females, n (%) 494 (62.5) 24 (63.2) 25 (59.5) 0.82
Household members, mean (SD) 5.0 (1.6) 4.6 (1.4) 5.2 (1.7) 0.10
Electricity, n (%) 164 (20.6) 4 (10.8) 9 (21.4) 0.23
Number of bed nets per household, mean (SD) 1.7 (1.3) 1.5 (1.2) 1.7 (1.1) 0.34
Slept under a bed net prior night, n (%)* 629 (78.6) 26 (68.4) 32 (76.2) 0.46
Using a treated net 514 (81.7) 23 (88.5) 28 (87.5) 1.00
Using a torn net 239 (38.0) 9 (34.6) 11 (34.4) 1.00
Reported fever within prior 24 hours, n (%) 108 (13.5) 11 (29.0) 6 (14.3) 0.17
Malaria treatment during prior 2 weeks, n (%) 50 (6.3) 2 (5.3) 1 (2.4) 0.60
Hospitalized during preceding 3 months for malaria, n (%) 17 (2.1) 0 (0) 0 (0) –
Hemoglobin (g/dL), mean (SD) 12.0 (1.7) 11.5 (1.8) 12.1 (1.9) 0.12
Age group (years)
< 5 11.2 (1.3) 10.8 (2.2) 11.5 (1.6) 0.37
≥ 5 to < 20 12.4 (1.3) 11.6 (1.3) 12.5 (1.0) 0.05
≥ 20 13.1 (1.8) 12.1 (1.9) 13.4 (2.6) 0.22
Parasites/mL blood, median (IQR) – 896 (198–15,798) – –
Age group (years)
< 5 – 834 (595–20,673) – –
≥ 5 to < 20 – 5,794 (303–21,710) – –
≥ 20 – 675 (23–1,905) – –
IQR = interquartile range; SD = standard deviation.
*Proportion calculated using all subjects. All other proportions exclude those with missing data.
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ultrasensitive assay to evaluate microscopy-positive but RDT-/
PCR-negative results, and successfully identified low-level
parasitemia in one of 12 subjects.
The hrp2-deleted P. falciparum parasite identified in this
study represents the first suspected case reported in Malawi.
There are increasing reports of these stealth parasites, which
evade detection by RDTs that depend upon identification of
circulating P. falciparum HRP2 antigen, but their public
health significance remains unknown.9,12
In conclusion, we used an epidemiological and molecular
approach to evaluate the diagnostic methods used during a
large MTI study conducted as part of the RTS,S/ASO1 vac-
cine trials. Our findings confirm that RDT and microscopy
underestimate the prevalence of P. falciparum parasitemia.
RDTs may currently lack the sensitivity and specificity for
accurate assessment of transmission intensity.12,19 Molecular
methods should be considered for use in future transmission
studies as a supplement to RDT or microscopy.
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